We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
In the latest market close, Danaher (DHR - Free Report) reached $216.87, with a +0.37% movement compared to the previous day. The stock outperformed the S&P 500, which registered a daily loss of 0.13%. Elsewhere, the Dow saw a downswing of 0.03%, while the tech-heavy Nasdaq depreciated by 0.12%.
The the stock of industrial and medical device maker has fallen by 15.92% in the past month, lagging the Conglomerates sector's loss of 10.56% and the S&P 500's loss of 5.53%.
Analysts and investors alike will be keeping a close eye on the performance of Danaher in its upcoming earnings disclosure. The company's earnings report is set to go public on October 24, 2023. In that report, analysts expect Danaher to post earnings of $1.87 per share. This would mark a year-over-year decline of 26.95%. Meanwhile, our latest consensus estimate is calling for revenue of $6.63 billion, down 13.46% from the prior-year quarter.
For the annual period, the Zacks Consensus Estimates anticipate earnings of $8.82 per share and a revenue of $28.49 billion, signifying shifts of -19.45% and -9.47%, respectively, from the last year.
Investors might also notice recent changes to analyst estimates for Danaher. These recent revisions tend to reflect the evolving nature of short-term business trends. Consequently, upward revisions in estimates express analysts' positivity towards the company's business operations and its ability to generate profits.
Empirical research indicates that these revisions in estimates have a direct correlation with impending stock price performance. To exploit this, we've formed the Zacks Rank, a quantitative model that includes these estimate changes and presents a viable rating system.
The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate has shifted 0.16% downward. Right now, Danaher possesses a Zacks Rank of #3 (Hold).
In terms of valuation, Danaher is currently trading at a Forward P/E ratio of 24.49. This indicates a premium in contrast to its industry's Forward P/E of 15.38.
It's also important to note that DHR currently trades at a PEG ratio of 2.33. The PEG ratio is similar to the widely-used P/E ratio, but this metric also takes the company's expected earnings growth rate into account. DHR's industry had an average PEG ratio of 1.79 as of yesterday's close.
The Diversified Operations industry is part of the Conglomerates sector. Currently, this industry holds a Zacks Industry Rank of 150, positioning it in the bottom 41% of all 250+ industries.
The Zacks Industry Rank evaluates the power of our distinct industry groups by determining the average Zacks Rank of the individual stocks forming the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Don't forget to use Zacks.com to keep track of all these stock-moving metrics, and others, in the upcoming trading sessions.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
(DHR) Gains As Market Dips: What You Should Know
In the latest market close, Danaher (DHR - Free Report) reached $216.87, with a +0.37% movement compared to the previous day. The stock outperformed the S&P 500, which registered a daily loss of 0.13%. Elsewhere, the Dow saw a downswing of 0.03%, while the tech-heavy Nasdaq depreciated by 0.12%.
The the stock of industrial and medical device maker has fallen by 15.92% in the past month, lagging the Conglomerates sector's loss of 10.56% and the S&P 500's loss of 5.53%.
Analysts and investors alike will be keeping a close eye on the performance of Danaher in its upcoming earnings disclosure. The company's earnings report is set to go public on October 24, 2023. In that report, analysts expect Danaher to post earnings of $1.87 per share. This would mark a year-over-year decline of 26.95%. Meanwhile, our latest consensus estimate is calling for revenue of $6.63 billion, down 13.46% from the prior-year quarter.
For the annual period, the Zacks Consensus Estimates anticipate earnings of $8.82 per share and a revenue of $28.49 billion, signifying shifts of -19.45% and -9.47%, respectively, from the last year.
Investors might also notice recent changes to analyst estimates for Danaher. These recent revisions tend to reflect the evolving nature of short-term business trends. Consequently, upward revisions in estimates express analysts' positivity towards the company's business operations and its ability to generate profits.
Empirical research indicates that these revisions in estimates have a direct correlation with impending stock price performance. To exploit this, we've formed the Zacks Rank, a quantitative model that includes these estimate changes and presents a viable rating system.
The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate has shifted 0.16% downward. Right now, Danaher possesses a Zacks Rank of #3 (Hold).
In terms of valuation, Danaher is currently trading at a Forward P/E ratio of 24.49. This indicates a premium in contrast to its industry's Forward P/E of 15.38.
It's also important to note that DHR currently trades at a PEG ratio of 2.33. The PEG ratio is similar to the widely-used P/E ratio, but this metric also takes the company's expected earnings growth rate into account. DHR's industry had an average PEG ratio of 1.79 as of yesterday's close.
The Diversified Operations industry is part of the Conglomerates sector. Currently, this industry holds a Zacks Industry Rank of 150, positioning it in the bottom 41% of all 250+ industries.
The Zacks Industry Rank evaluates the power of our distinct industry groups by determining the average Zacks Rank of the individual stocks forming the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Don't forget to use Zacks.com to keep track of all these stock-moving metrics, and others, in the upcoming trading sessions.